Effects of different routes of administration on the immunogenicity of the Tat protein and a Tat-derived peptide

Documenti analoghi

• The HIV-1 Tat Protein Induces the Activation of CD8(+) T Cells and Affects In Vivo the Magnitude and Kinetics of Antiviral Responses
  di: Nicoli, Francesco, et al.
  Pubblicazione: (2013)
• The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral Reactivation
  di: Nicoli, Francesco, et al.
  Pubblicazione: (2020)
• An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge
  di: Sicurella, Mariaconcetta, et al.
  Pubblicazione: (2014)
• Proteasome inhibitors induce the presentation of an Epstein–Barr virus nuclear antigen 1-derived cytotoxic T lymphocyte epitope in Burkitt's lymphoma cells
  di: Destro, Federica, et al.
  Pubblicazione: (2011)
• Intracellular HIV-1 Tat protein represses constitutive LMP2 transcription increasing proteasome activity by interfering with the binding of IRF-1 to STAT1
  di: Remoli, Anna L., et al.
  Pubblicazione: (2006)